New test predicts dementia 20 years ahead
The dementia risk score is a novel approach for the prediction of the risk of late-life dementia in people of middle-age, according to new research from Karolinska Institutet. Dr. Miia Kivipelto and colleagues conducted a population-based study called CAIDE (Cardiovascular Risk Factors, Aging and Dementia) among 1409 randomly selected individuals aged 65-79 from Eastern Finland. The study was collaboration between Aging Research Center, Karolinska Institutet in Sweden, and University of Kuopio, and National Public Health Institute in Finland. The participants of the CAIDE study had been previously surveyed for their weight, height, cholesterol and blood pressure levels in the frame-work of North Karelia Project and FINMONICA study in 1972, 1977, 1982 or 1987 when they were around 50 years. The investigators re-examined the participants about 20 years later in 1998 for signs of dementia.
The authors wanted to develop a simple scoring tool that could be used to calculate the risk of dementia for a person that has a certain set of risk factors at midlife. The dementia risk score included variables that were significantly associated with the risk of dementia later in life, including age, education, blood pressure, serum cholesterol values, body mass index and physical activity at midlife. The dementia risk score predicted dementia well and the probability of dementia increased as the risk score became greater.
The authors point out that the dementia risk score highlights the role of vascular and lifestyle related factors in the development of dementia, and could help to identify individuals who might benefit from intensive lifestyle consultations and pharmacological interventions. The authors also remind that the risk score should be validated and further improved (e.g. by adding new variables) to increase its predictive value.
Original publication: M. Kivipelto, T. Ngandu, T. Laatkainen, B. Winblad, H. Saininen, Jaakko Toumietho; "Risk score for prediction of dementia risk in 20 years among middle-aged people: a longitudinal, population based study."; Lancet Neurology 2006.
Most read news
Other news from the department science
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Rapid diagnosis of diseases with novel blood test
Toxic chemicals found in common scented laundry products, air fresheners
Laboratory specialist KNAUER receives "Grand Prize for Medium-Sized Businesses"
ISQ 7610 | GC/MS-systems | Thermo Fisher Scientific
Alan Schafer to head Population Genetics
Charged Aerosol Detectors | Charged aerosol detectors | Thermo Fisher Scientific
Gilson announces new partners in the UK and Eire
Copley Scientific appoints new distributors in Turkey, Brazil and China
Motion pictures from living cells - Research team improves superresolution microscopy